| Gustafsson, Finn |
| Not yet recruiting | 4 | 17 | NA | Vericiguat, Placebo | Finn Gustafsson, Aarhus University Hospital | Heart Failure, Pulmonary Arterial Hypertension | 12/24 | 01/26 | | |
| Recruiting | 4 | 60 | Europe | CardioMEMS HF System, Standard heart failure medical therapy | Finn Gustafsson, Novo Nordisk A/S, Abbott | Advanced Heart Failure, Heart Failure With Reduced Ejection Fraction | 12/25 | 12/25 | | |
| Recruiting | 4 | 1500 | Europe | Hydralazine Isosorbide Dinitrate, BiDil, Placebo Oral Tablet, Metformin Hydrochloride | Henrik Wiggers, Danish Heart Foundation, Danish Council for Independent Research, The Danish Regions: Foundation for Medical Research, The Novo Nordisk Foundation, The Aase og Ejnar Danielsen Foundation | Heart Failure, Diabetes | 12/26 | 12/26 | | |
| Recruiting | 3 | 288 | Europe, US, RoW | Methylprednisolone, saline solution | Niguarda Hospital, Ministry of Health, Italy, Istituto Di Ricerche Farmacologiche Mario Negri, University of Milano Bicocca, Regione Lombardia | Myocarditis Acute | 03/28 | 12/28 | | |
| Terminated | 2 | 51 | Europe | Entresto Pill, Valsartan+ sacubitril | Jacob Moller, Danish Heart Foundation, Odense University Hospital, Rigshospitalet, Denmark | Myocardial Infarction, Diastolic Dysfunction | 07/22 | 06/23 | | |
Act-VAD, NCT04732039: Daily Life Activities in Patients Treated With Continuous-Flow Left Ventricular Assist Devices |
|
|
| Recruiting | N/A | 50 | Europe | Measurement of peak oxygen uptake | Rigshospitalet, Denmark | Left Ventricular Failure, Unspecified | 12/22 | 12/22 | | |
CuDOSIS, NCT06131112: Macrophage PET/CT Imaging Using 64Cu-DOTATATE for the Diagnosis of Cardiac Sarcoidosis |
|
|
| Recruiting | N/A | 76 | Europe | 64Cu-DOTATATE PET/CT scan | Rigshospitalet, Denmark | Cardiac Sarcoidosis | 01/26 | 01/27 | | |
| Recruiting | N/A | 400 | Europe | Cardiopulmonary exercise test, NT-proBNP, Echocardiography, 6 minute walk test, Right heart catheterization | Rigshospitalet, Denmark, Novo Nordisk A/S | Heart Failure With Reduced Ejection Fraction | 12/25 | 12/25 | | |
PRO-VAD, NCT04423562: PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices |
|
|
| Recruiting | N/A | 500 | Europe | No intervention | Rigshospitalet, Denmark | Left Ventricular Assist Device, Prognosis, Advanced Heart Failure | 12/22 | 12/22 | | |
